Dr. Madinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
- University of ColoradoFellowship, Infectious Disease, 1988 - 1992
- Cedars-Sinai Medical CenterResidency, Internal Medicine, 1987 - 1988
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1984 - 1987
- David Geffen School of Medicine at UCLAClass of 1984
Certifications & Licensure
- CA State Medical License 1985 - Present
- CO State Medical License 1987 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 6 citationsSeasonal variations and risk factors ofinfection: a multicenter research network study.Matthew Kennis, Alex Tagawa, Vanessa M Kung, Gabrielle Montalbano, Isabella Narvaez
Therapeutic Advances in Infectious Disease. 2022-10-19 - 17 citationsBartonella quintana Infection in People Experiencing Homelessness in the Denver Metropolitan Area.Zachary Shepard, Lilian Vargas Barahona, Gabrielle Montalbano, Sarah E Rowan, Carlos Franco-Paredes
The Journal of Infectious Diseases. 2022-10-07 - 3 citationsFalse-positive rapid diagnostic test for malaria in new world cutaneous leishmaniasis: a tale of two travelers.Rebecca Unterborn, Jose Henao-Cordero, Arianna Kousari, Poornima Ramanan, Carlos Franco-Paredes
Therapeutic Advances in Infectious Disease. 2022-05-09
Press Mentions
- Facile Accelerated Specific Therapeutic (FAST) Platform Develops Antisense Therapies to Counter Multidrug-Resistant BacteriaMarch 12th, 2021
- Multiplexed Deactivated CRISPR-Cas9 Gene Expression Perturbations Deter Bacterial Adaptation by Inducing Negative EpistasisSeptember 3rd, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: